Leerink 2025 Global Healthcare Conference March 10, 2025 9:20 AM ETCompany ParticipantsLucas Montarce - CFOMike Czapar ...

OSI Systems, Inc. (NASDAQ: OSIS), today announced that Alan Edrick, CFO, will participate in a fireside chat at the J.P. Morgan 2025 Industrials Conference on Tuesday, March 11, 2025, at 4:10 PM ET.

The diabetes and weight loss drug market is heating up in 2025, with significant growth signs everywhere. According to a recent study from Research and Markets, industry growth is running at an ...

Fortive Corporation ("Fortive") (NYSE: FTV) today announced that James A. Lico, President and Chief Executive Officer, and Olumide Soroye, President and Chief Executive Officer of Intelligent ...

Hedge funds still have big bets on the market, but they don't appear to be as bullish as they previously were, according to an analysis from J.P. Morgan. The Wall Street giant found that gross ...

LyondellBasell today announced Peter Vanacker, chief executive officer, will participate in a fireside chat at the J.P.

In the second podcast in a special series focused on BioSpace’s NextGen Class of 2025, Senior Editor Annalee Armstrong speaks with Kevin Marks, CEO of Delphia Therapeutics.

Delphia didn’t just have to introduce itself to the world when it broke out of stealth in May 2024; it had to debut an ...

Big Pharma executives feel optimistic about their industry’s trajectory under a second Donald Trump presidency, with regulation rollbacks and other changes likely to boost bottom lines for drugmakers, ...

Just nine weeks after UnitedHealthcare CEO Brian Thompson was murdered on a weekday morning on a busy street, the luminaries ...

The life sciences industry experienced a dynamic year in 2024. As the public markets gained traction, IPO activity and venture investment saw ...

Achieved Q4 2024 and full year 2024 OJEMDA™ (tovorafenib) net product revenues of $29.0 million and $57.2 million, respectivelyEnded 2024 with ...